INmune Bio, Inc. (INMB) vs Precision Optics Corporation, Inc. (POCI)

A side-by-side comparison of INmune Bio, Inc. and Precision Optics Corporation, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — INMB vs POCI

growth of $100 · dividends reinvested · last 8y
INMB -75.7% (-16.2%/yr)POCI +29.3% (+3.3%/yr)POCI compounded faster over this window
Log scale — wide-divergence pair
101001kStart $100202120232025$24$129
INMB POCI

INMB vs POCI: by the numbers

  • •INMB is the larger company ($50M vs $49M market cap).
  • •Both run net losses; POCI's is the smaller (-11.51% vs -91866.00% net margin).

Metrics side by side

Valuation

MetricINMBPOCI
P/S ratioN/A1.56
P/B ratio2.442.42

Profitability

MetricINMBPOCI
Gross margin100.00%17.22%
Operating margin-61738.00%-11.13%
Net margin-91866.00%-11.51%
ROE-90.44%-17.84%
ROIC-96.37%-14.57%

Growth (annualized)

MetricINMBPOCI
Revenue CAGR (5Y)N/A24.19%
Total return CAGR (5Y)-36.88%-5.76%

Frequently asked

How have INMB and POCI total returns compared?
Over the past 5 years, INMB delivered -36.88% and POCI delivered -5.76% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.